About Tissue Growth Technologies
Tissue Growth Technologies is a Healthcare company based in Minneapolis (United States) founded in 2000, and was acquired by Instron in May 2013. It operates as a bioreactor systems for 3D cell culture and tissue growth. Its chief executive is Ramakrishna Hebbar. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its competitors include Pluri, AIM Biotech, Celloid, S-BIO and The Well Bioscience and 5 more; 2 of its 10 listed competitors have raised funding.
Company details
Tissue Growth Technologies was founded in 2000 in Minneapolis, United States, and operates in the biotechnology sector focused on tissue engineering. Bioreactor systems are developed to mimic in vivo conditions, supporting applications in cellular mechanism studies, stem cell proliferation, and drug discovery. The company was acquired by Instron in 2013 for an undisclosed amount, with Instron later acquired by BISS.
- Headquarters Minneapolis, United States
- Stage Acquired
- SectorsHealthcare
- Website tissuegrowth.com
- Social LinkedIn X
- Acquired by Instron (May 2013)
Investors in Tissue Growth Technologies
Tissue Growth Technologies has secured backing from 1 investor. Prominent investors backing the company include Instron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Testing machines for materials are manufactured and distributed worldwide. | 1946 | instron.com | Norwood, United States |
Investor details for Tissue Growth Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tissue Growth Technologies
1 people are tracked at Tissue Growth Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ramakrishna Hebbar | CEO | Leadership |
Complete people profiles for Tissue Growth Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Tissue Growth Technologies
2 dated milestones of Tissue Growth Technologies across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Tissue Growth Technologies is founded.
- Exit Acquired by Instron.
Competitors of Tissue Growth Technologies
Tissue Growth Technologies has 10 listed competitors in our database, 2 of them funded. They include Pluri, AIM Biotech, Celloid, S-BIO and The Well Bioscience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pluri-biotech.com | 2003 | Haifa, Israel | – | – | Next-generation cell-based products are developed across multiple industries. | |
| aimbiotech.com | 2012 | Singapore | – | – | Microfluidic 3D cell culture systems are developed and manufactured. | |
| celloid.co.kr | 2021 | – | $1.8M | – | 3D cell culture solutions for drug development are provided. | |
| s-bio.com | 2005 | Hudson, United States | – | – | Glycan analysis services and kits are offered by S-BIO. | |
| thewellbio.com | 2015 | Newark, United States | – | – | Develops xeno-free hydrogels for 3D cell culture and personalized medicine applications. | |
| excell-matrix.com | 2005 | Hyderabad, India | – | – | Proprietary 3D cell culture technologies are provided for tissue engineering. | |
| peptimatrix.com | 2022 | Nottingham, United Kingdom | $906,411 | – | Provider of a peptide hydrogel platform for 3D cell culture | |
| lifetaq.at | 2017 | – | – | – | Provides automated 3D cell cultivation units for accurate in vitro research models. | |
| cellaven.com | 2022 | Dijon, France | – | – | Creates innovative automated cell culture devices for life science laboratories. | |
| cellatopia.tcc.mode | 2023 | Suzhou, China | – | – | Biomedical tools for cell reproducibility and reliability are developed. |
Detailed competitors of Tissue Growth Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Tissue Growth Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tissue Growth Technologies
Tissue Growth Technologies was founded in 2000.
Tissue Growth Technologies is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Ramakrishna Hebbar is the current CEO of Tissue Growth Technologies.
Tissue Growth Technologies was founded in 2000 in Minneapolis, United States, and operates in the biotechnology sector focused on tissue engineering. Bioreactor systems are developed to mimic in vivo conditions, supporting applications in cellular mechanism studies, stem cell proliferation, and drug discovery. The company was acquired by Instron in 2013 for an undisclosed amount, with Instron later acquired by BISS.
Tissue Growth Technologies's top competitors include Pluri, Celloid and ExCel Matrix Biological Devices.
Tissue Growth Technologies has 1 investor. Key investors include Instron.
Yes. Tissue Growth Technologies was acquired by Instron in May 2013.